HTH-02-006   Click here for help

GtoPdb Ligand ID: 11085

Compound class: Synthetic organic
Comment: HTH-02-006 is a reversible small-molecule inhibitor of the Hippo pathway kinase, NUAK2 [3]. It can be used as a tool compound to investigate the role of NUAK2 in cancer and other Hippo pathway-associated biological processes [1-2]. HTH-02-006 is a derivative of the prototype NUAK inhibitor WZ4003. It is active in vivo.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 91.85
Molecular weight 588.13
XLogP 4.34
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES CCC(=O)Nc1cccc(c1)Oc1nc(ncc1I)Nc1ccc(cc1OC)N1CCN(CC1)C
Isomeric SMILES CCC(=O)Nc1cccc(c1)Oc1nc(ncc1I)Nc1ccc(cc1OC)N1CCN(CC1)C
InChI InChI=1S/C25H29IN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30)
1. Dey A, Varelas X, Guan KL. (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.
Nat Rev Drug Discov, 19 (7): 480-494. [PMID:32555376]
2. Juan WC, Hong W. (2016)
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Genes (Basel), 7 (9). [PMID:27589805]
3. Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. (2018)
NUAK2 is a critical YAP target in liver cancer.
Nat Commun, 9 (1): 4834. [PMID:30446657]